Intest Res Search

CLOSE


‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).
The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

April 29, 2022


Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
Sang Hyoung Park
Intest Res. 2022;20(2):159-164.

Review

January 7, 2022


Artificial intelligence for endoscopy in inflammatory bowel disease
Kento Takenaka, Ami Kawamoto, Ryuichi Okamoto, et al.
Intest Res. 2022;20(2):165-170.

Statement

January 5, 2022


SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID
Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, et al.
Intest Res. 2022;20(2):171-183.

Original Article

May 4, 2021


Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
Saurabh Kedia, Raju Sharma, Sudheer Kumar Vuyyuru, et al.
Intest Res. 2022;20(2):184-191.

Original Article

April 29, 2022


Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study
Eun Soo Kim, Chung Hyun Tae, Sung-Ae Jung, et al.
Intest Res. 2022;20(2):192-202.

Original Article

April 29, 2022


Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study
Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, et al.
Intest Res. 2022;20(2):203-212.

Original Article

April 29, 2022


Drug therapy and monitoring for inflammatory bowel disease: a multinational questionnaire investigation in Asia
Chenwen Cai, Juntao Lu, Lijie Lai, et al.
Intest Res. 2022;20(2):213-223.

Original Article

February 8, 2022


Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease
Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, et al.
Intest Res. 2022;20(2):224-230.

Original Article

February 8, 2022


Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study
Bhaskar Kante, Pabitra Sahu, Saurabh Kedia, et al.
Intest Res. 2022;20(2):231-239.

Original Article

February 8, 2022


Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
Fares Ayoub, Matthew Odenwald, Dejan Micic, et al.
Intest Res. 2022;20(2):240-250.

Original Article

February 8, 2022


Fecal microbiota transplantation for induction of remission, maintenance and rescue in patients with corticosteroid-dependent ulcerative colitis: a long-term follow-up real-world cohort study
Avnish Kumar Seth, Priti Jain
Intest Res. 2022;20(2):251-259.

Original Article

April 29, 2022


One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study
Yuichi Matsuno, Takehiro Torisu, Junji Umeno, et al.
Intest Res. 2022;20(2):260-268.
Is fecal microbiota transplantation effective in corticosteroid-dependent ulcerative colitis?

Epub April 29, 2022

Are thiopurines safe and effective for patients with NUDT15 heterozygosity?

Epub February 7, 2022

How often is immunoglobulin A nephropathy associated in patients with inflammatory bowel diseases?

Epub November 2, 2021

Could the geographic area influence the demographic profile of IBD patients in India?

Epub April 29, 2021

Could melatonin ameliorate the intestinal inflammation by modulating intestinal microbial composition?

Epub August 10, 2020

What are the risk factors for impaired ovarian reserve in young women of reproductive age with Crohn's disease?

Epub April 22, 2020

Who should continue the budesonide 2-mg foam treatment for up to week 6 in patients with mild-to-moderate distal ulcerative colitis?

Epub February 18, 2020

How common is family history of inflammatory bowel disease and how does it relate to the prognosis in patients with inflammatory bowel disease in Asia?

Epub October 13, 2019

Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study

Epub August 2, 2019

Influence of anti-tumor necrosis factor-alpha therapy on pregnant women with inflammatory bowel disease and their children’s immunity

Epub April 23, 2019

Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis

Epub February 7, 2019

Fecal immunochemical test and fecal calprotectin in ulcerative colitis

Epub November 1, 2018

Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease

Epub August 9, 2018

Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study

Epub May 8, 2018

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment

Epub February 5, 2018

Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease

Epub November 2, 2017

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease

Epub September 1, 2017

  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD

ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2022 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next
Close layer
prev next